T2D: increased hepatic Risk due to Components of metabolic Syndrome?

被引：0
|
作者：
Clauss, R. Maria
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2024年 / 19卷 / 04期
关键词：
D O I：
10.1055/a-2311-3516
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes (T2D) is associated with a significant risk of liver damage, including cirrhosis and liver cancer. T2D often develops on the basis of metabolic syndrome (MetS) and is therefore often present together with other MetS symptoms, such as high blood pressure, obesity, low HDL, hypertriglyceridemia and albuminuria. It is not certain whether this results in an additive risk of liver damage.
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [31] MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D
    Motawae, Tarek M.
    Ismail, Manal F.
    Shabayek, Marwa I.
    Seleem, Mae M.
    PLOS ONE, 2015, 10 (05):
  • [32] Multiple Lifestyle Interventions: Impact On Metabolic Health In Patients With Prediabetes And T2D
    Jacobsen-Maurasse, Malika-Lisa
    Chenette-Stewart, Olivier
    Latour, Elise
    Lamoureux, Karine
    Aubut, Lise
    Dionne, Valerie
    Hamrioui, Nacima
    Guilbeault, Valerie
    Morin, Juliette
    Martin, Sarah-Maude
    Tanguay, Sophie
    L'Allier, Phillipe L.
    Juneau, Martin
    Gayda, Mathieu
    Inglesies-Grau, Josep
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 911 - 913
  • [33] Acne Increased Risk for a metabolic Syndrome
    Meinrenken, Susanne
    AKTUELLE DERMATOLOGIE, 2016, 42 (10) : 392 - 392
  • [34] Re: Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2016, 196 (04): : 1125 - 1126
  • [35] A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
    Eusebio Chiefari
    Sinan Tanyolaç
    Stefania Iiritano
    Angela Sciacqua
    Carmelo Capula
    Biagio Arcidiacono
    Aurora Nocera
    Katiuscia Possidente
    Francesco Baudi
    Valeria Ventura
    Giuseppe Brunetti
    Francesco S. Brunetti
    Raffaella Vero
    Raffaele Maio
    Manfredi Greco
    Maria Pavia
    Ugur Hodoglugil
    Vincent Durlach
    Clive R. Pullinger
    Ira D. Goldfine
    Francesco Perticone
    Daniela Foti
    Antonio Brunetti
    Scientific Reports, 3
  • [36] Semaglutide Increases the Proportion of People with T2D Achieving a Metabolic Composite Endpoint
    Ji, Linong
    Ahmann, Andrew
    Ahren, Bo
    Capehorn, Matthew
    Hu, Ping
    Lingvay, Ildiko
    Liu, Wenyan
    Rodbard, Helena W.
    Shen, Zewei
    Sorli, Christopher H.
    DIABETES, 2023, 72
  • [37] Apolymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components
    Chiefari, Eusebio
    Tanyolac, Sinan
    Iiritano, Stefania
    Sciacqua, Angela
    Capula, Carmelo
    Arcidiacono, Biagio
    Nocera, Aurora
    Possidente, Katiuscia
    Baudi, Francesco
    Ventura, Valeria
    Brunetti, Giuseppe
    Brunetti, Francesco S.
    Vero, Raffaella
    Maio, Raffaele
    Greco, Manfredi
    Pavia, Maria
    Hodoglugil, Ugur
    Durlach, Vincent
    Pullinger, Clive R.
    Goldfine, Ira D.
    Perticone, Francesco
    Foti, Daniela
    Brunetti, Antonio
    SCIENTIFIC REPORTS, 2013, 3
  • [38] The Gut Microbiome and Puberty in Girls at Risk for Type 2 Diabetes (T2D)
    Jobira, Beza
    Frank, Daniel N.
    Pyle, Laura
    Gross, Susan
    Ir, Diana
    Pendleton, Wesley
    Robertson, Charles E.
    Nadeau, Kristen J.
    Kelsey, Megan M.
    DIABETES, 2019, 68
  • [39] SGLT2i Use and the Risk of Nephrolithiasis in Patients with T2D
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary
    Mastrorilli, Julianna M.
    Wexler, Deborah J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [40] PowerHouse: A Lifestyle Intervention for Youth at Risk for Type 2 Diabetes (T2D)
    El Mikati, Hala K.
    Pike, Julie
    Haberlin-Pittz, Katie
    Yazel-Smith, Lisa
    Mckinney, Brett M.
    Hannon, Tamara S.
    DIABETES, 2019, 68
12345